[rev_slider alias="slideme"]

About Laure KAINANE

Posts by Laure KAINANE:

PARTAGER

Middle letters and imitation

On January 9, 2008 the French Trademarks Office ruled positively our opposition and admitted a likelihood of confusion between TRILEPTAL and TRIPLIXAL.The Opposition Division analyzed the resemblance due to the 7 letters in common, same sequence TRI/L/AL same rhythm and close sonorities to conclude that TRIPLIXAL constitutes the imitation of TRILEPTAL.
The difference between middle letters  does not affect the … Read the rest
PARTAGER

Prefixes and Intellect: the good combination against imitation

On February 13, 2008 the European Court of First Instance (ECFI) ruled that the marks URION and ATURION were not confusingly similar for pharmaceuticals goods

The ECFI first defined the pertinent public for pharmaceuticals sold on prescription as being composed of professionals and patients with a high degree of attention. This complies with the earlier cases TRAVATAN (2005), ALREX (2005), … Read the rest

PARTAGER

Focus on the French Health Products Safety Agency

Focus on the French Health Products Safety Agency

The French Health Products Safety Agency (Afssaps) was created by the law of 1 July 1998, passed to strengthen existing monitoring and health safety systems, in order to provide an improved response to the increasing diversity and interaction of health safety issues relating to healthcare products.

The Afssaps was set up in … Read the rest

PARTAGER

Flash On CURON vs./ EURON

 

On February 13, 2007, the CFI issued a decision stating that these marks, covering products in class 10, are dissimilar.

The Court took the view that the pertinent public was composed of both average consumers and a majority of health professionals. It considered EURO as the dominant element of EURON because the public was familiar with it, which is quite … Read the rest

PARTAGER

ALREX vs./ ARTEX

 

ALREX vs./ ARTEX

In the ALREX vs./ ARTEX case, further to the appeal filed against the European Court of First Instance decision, the Advocate General gave his opinion: The acquisition decision is made when the medicine is prescribed by professionals. Thus, when a comparison is made between two pharmaceuticals available only on prescription the relevant public is professional. If one … Read the rest

PARTAGER

Exclusive Interview of Mrs. Sophie Lalaude in charge of the “Name Work group” (NWG) at the AFSSAPS (French Health Products Safety Agency) – PART I What is the role of the NWG?

 Focus on the French Health Products Safety Agency   

The French Health Products Safety Agency (Afssaps) was created by the law of 1 July 1998, passed to strengthen existing monitoring and health
safety systems, in order to provide an improved response to the increasing diversity and interaction of health safety issues relating to healthcare products. The Afssaps was set up in
Read the rest